The way forward for Ketamine and Mood Disorders In 2019, the FDA and European Fee authorised the usage of an esketamine nasal spready under the manufacturer identify Spravato to deal with depression. Having said that, as of 2021, ketamine has not been permitted with the FDA to deal with melancholy or other mental wellness disorders, and for that re